BullFrog AI Secures $200K from TEDCO’s Seed Fund
Summary
Our mission is to find the link between therapies and patients and improve their lives,” said BullFrog AI’s Founder and CEO, Vin Singh. “Using our proprietary technology platform, we aim to predict which patients will benefit from which medications, effectively improving clinical outcomes and eliminating the problem of trial-and-error prescriptions.” BullFrog AI uses a proprietary artificial intelligence platform called bfLEAPTM that enables biopharmaceutical companies to be more successful in their clinical development programs. The Seed Fund money will contribute to additional development work with John Hopkins University Applied Physics Laboratory not-for-profit research center. “Vin Singh is an experienced entrepreneur and TEDCO is excited to be partnered with Vin and BullFrog.” For more information on BullFrog AI, visit http://www.bullfrogai.com. Its proprietary bfLEAPTM analytics engine is the only tool of its kind, designed to analyze massive, complex, multi-factorial clinical data sets.